Filippo Riva
Amministratore Delegato presso Humabs BioMed SA
Posizioni attive di Filippo Riva
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Amministratore Delegato | 01/09/2015 | - |
| Direttore Finanziario/CFO | 01/04/2014 | 01/08/2017 |
Storia della carriera di Filippo Riva
Precedenti posizioni note di Filippo Riva
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Bmob Sagl | Direttore Finanziario/CFO | - | - |
| Fondatore | - | - | |
Telormedix SA
 Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Direttore Finanziario/CFO | - | - |
Formazione di Filippo Riva
| Warwick Business School | Masters Business Admin |
| School of Economics & Business Administration | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 5 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Founder | 1 |
| Masters Business Admin | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Telormedix SA
Telormedix SA Pharmaceuticals: MajorHealth Technology Telormedix SA operates as a biopharmaceutical company, that focuses on targeted immunity in the treatment of cancer and other diseases. Its products include TMX-101 for the treatment of localized bladder cancer, TMX-201 for the topical treatment of bladder cancer, skin cancer, and other indications, as well as for use as a vaccine adjuvant, and TMX-302 for use in preclinical trials for the treatment of autoimmune disease. The company was founded in October 2007 by Lorenzo Leoni, Roberto Maj, Rolf M. Zinkernagel and Dennis A. Carson and is headquartered in Lugano, Switzerland. | Health Technology |
| Bmob Sagl | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Filippo Riva
- Esperienza
